Xphos, min. 97%, 1 g, glass packaging

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromo-1H-indol-3-yl)propanoic acid, 98%, 25g

4-(Benzo[d][1,3]dioxol-5-yl)butan-2-one, 95.0%, 500g

4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)tetrahydro-2H-pyran-4-carboxylic acid, 95.0%, 10g

(3-Ethylphenyl)(phenyl)methanone, 95.0%, 5g

2-Chloro-4-(1H-imidazol-1-yl)benzaldehyde, 95.0%, 5g

Methyl 2-(Chlorosulfonyl)-3-methoxythiophene-4-carboxylate, 97.0%, 5g

2-Ethyl-2-phenylbutanenitrile, 97%, 1g

(S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)(METHYL)AMINO)-3-(1-TRITYL-1H-IMIDAZOL-4-YL)PROPANOIC ACID, 95%, 25mg

2-Bromo-3-fluoroisonicotinic acid, 95.0%, 100g

3-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-1-propanamine, 5g

4-(Difluoromethoxy)-3-nitrobenzaldehyde, 250mg

(imidazo[1,2-a]pyrimidin-2-ylmethyl)amine dihydrochloride hydrate, 95.0%, 10g